AstraZeneca

From WikiMD's WELLNESSPEDIA

(Redirected from AstraZeneca Pharmaceuticals LP)

AstraZeneca is a multinational pharmaceutical and biopharmaceutical company. It was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. The company's headquarters are located in Cambridge, United Kingdom.

History[edit]

Astra AB was founded in 1913 in Södertälje, Sweden, by 400 doctors and apothecaries. In 1993, the British chemicals company ICI demerged its pharmaceuticals businesses and its agrochemicals and specialties businesses, to form Zeneca Group.

In 1999, Astra AB and Zeneca Group announced their intention to merge, with the merger completed later that year, forming AstraZeneca plc. The company has made numerous acquisitions, including Cambridge Antibody Technology in 2006, MedImmune in 2007, and Definiens by MedImmune in 2014.

Products[edit]

AstraZeneca develops, manufactures and sells pharmaceutical and biopharmaceutical products. Some of its best-known products include the cancer drug Iressa, the asthma drug Pulmicort, the heart disease drug Crestor, and the gastrointestinal drug Nexium.

In 2020, AstraZeneca collaborated with the University of Oxford to develop a COVID-19 vaccine, known as AZD1222 or Vaxzevria.

Research and development[edit]

AstraZeneca's research and development efforts are focused on three main therapy areas: oncology, cardiovascular & metabolic disease and respiratory, inflammation & autoimmunity. The company is also active in neuroscience and infection.

Controversies[edit]

AstraZeneca has faced several controversies and legal actions over the years, related to drug safety, pricing and ethical practices.

See also[edit]

References[edit]


External links[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=AstraZeneca&oldid=6615599"